P ulmonary hypertension (PH) is relatively common among patients with congenital heart disease (CHD), 1,2 especially in conditions with pulmonary overcirculation and important volume and pressure overload (eg, large ventricular septal defect, aorto-pulmonary window, patent ductus arteriosus, or palliative arterial shunts). PH and right ventricular (RV) failure are strong predictors of mortality in CHD. 3, 4 Over the past decades, advances in pediatric cardiology and surgical techniques have increased the number of patients with CHD surviving into adulthood. However, decision on the optimal treatment or timing of a surgical repair remain challenging in several CHD (like, eg, in the presence of moderate-sized ventricular septal defects in asymptomatic small children). Indication may depend in some instances on PH and RV performance monitoring, which is difficult in this population. Children with PH are at a significantly higher risk of major complications during right heart catheterization (RHC), 5 and echocardiographic evaluation of the RV is complex, particularly in the presence of anatomic alterations.
Cardiac magnetic resonance (CMR) is the gold standard technique for the assessment of ventricular structure, function, and myocardial scarring. Additionally, it allows for accurate measurement of pulmonary-to-systemic flow ratio (Q p /Q s ) and may be helpful for quantifying and monitoring pulmonary vascular resistance (PVR). 6, 7 The presence of late gadolinium enhancement (LGE) in children and young adults with CHD is a prognostic marker. [8] [9] [10] In recent years, T1 mapping has emerged as a noninvasive technique for the quantification of myocardial extracellular volume (ECV), holding the promise of early detection of myocardial involvement not detectable by LGE. 11 In contrast to LGE imaging that detects patchy areas of dense scarring, T1 mapping evidences a diffuse fibrotic process. This novel technique has been scarcely used in this scenario. 12 We hypothesized that CMR may be useful to monitor serial changes in cardiac remodeling and pulmonary hemodynamics and may be able to detect early myocardial fibrosis in a translational animal model of aorto-pulmonary shunt.
The aorto-pulmonary shunt in growing piglets has become a well-established model of congenital conditions with leftto-right shunt. 13, 14 Hemodynamic measures taken at 3 and 6 months after surgery and pathobiology description of this swine model have been already published. 13, 15, 16 However, serial hemodynamic measurements and, more importantly, a comprehensive description of the progressive cardiac structural adaptation to this chronic volume and pressure overload have not been performed yet.
This study had, therefore, 2 main objectives: (1) to describe the CMR serial features of growing piglets with a large aorto-pulmonary shunt and to correlate them with serial data obtained from right RHC and computed tomography (CT); and (2) to quantify myocardial ECV by CMR in different ventricular territories in shunted animals and to evaluate their correlation with hemodynamic variables and cardiac performance.
Methods

Study Design
The study was designed into 2 substudies and included a total of twenty 4-week-old castrated male Large-White pigs.
Substudy 1 aimed to characterize serial cardiac adaptation to pulmonary overcirculation in 12 animals (aorto-pulmonary shunt [n=6] or sham operation [n=6]). Animals were evaluated monthly with RHC, CMR, and CT (all 3 techniques performed consecutively on the same day) during 4 months and underwent pathology analysis at completion. Substudy 2 aimed to quantify ECV by CMR in different regions of the myocardium 3 months after the intervention in 20 animals (aorto-pulmonary shunt [n=10] or sham operation [n=10]).
Our Institutional Animal Research Committee approved the study protocol. All animals received care in compliance with the Guide for the Care and Use of Laboratory Animals. Before any procedure, animals were anesthetized with an intramuscular injection of ketamine (20 mg/kg), xylazine (2 mg/kg), and midazolam (0.5 mg/kg). Buprenorphine (0.3 mg/kg) was used for analgesia, and animals were intubated.
All hemodynamic, CMR, and CT studies were performed under spontaneous ventilation, anesthesia with intravenous midazolam (0.2 mg/kg/h), and continuous electrocardiographic and pulsioxymetric monitoring.
Description of the Surgical Procedure for Aorto-Pulmonary Shunting
Surgery is performed through a 5 cm thoracotomy on the 4th left intercostal space. The pericardium is incised and the pulmonary artery (PA) is mobilized. The left innominate artery is also mobilized, proximally clamped in the aortic arch and ligated and divided as distally as possible. A side-biting clamp is placed in the main PA, and a 5 mm orifice is created. The distal innominate artery is then anastomosed to the main PA in an end-to-side fashion using interrupted polypropylene sutures ( Figure 1 ). Immediately after flow is restored, a continuous thrill inside the PA confirms correct shunt functionality. After appropriate hemostasis, the lung is re-expanded during chest closure, so no drainage is needed. Animals are extubated immediately after the procedure.
Control animals for this study underwent a sham operation as described earlier, in which the innominate artery was divided but the shunt was not performed.
Pigs undergoing shunting received a single dose of furosemide 40 mg EV immediately after surgery and oral aspirin100 mg daily during the first month.
RHC Studies
A femoral Swan-Ganz catheter positioned under fluoroscopy was used to measure pulmonary artery pressure (PAP) and cardiac output (CO) by the thermodilution method. A femoral arterial line was placed for continuous systemic blood pressure monitoring, and a pigtail catheter was placed inside the left ventricular (LV) cavity to measure LV end-diastolic pressure (LVEDP) as an estimate of left atrial pressure. PVR was calculated in Wood units as (mean PAP-LVEDP)/ CO. Indexed PVR and CO by body surface area were estimated using the Brody's formula. 17 
CMR Studies
Studies were performed using a 3.0-T TX Achieva system (Philips, the Netherlands). Steady-state free precession cine sequences were acquired in 10 to 15 contiguous short-axis slices covering both ventricles from base to apex for the evaluation of ventricular volumes and function. Twodimensional flow imaging (phase-contrast) was performed perpendicular to the main PA and ascending aorta with a velocity-encoded gradient echo sequence, as previously described. 7 In shunted animals, additional phase-contrast transversal imaging of the shunt was performed.
At third month postintervention, CMR imaging protocol included LGE and T1 mapping sequences in all cases. Gadolinium contrast (Magnevist; Bayer Schering Pharma) was administered at a dose of 0.1 mmol/kg for LGE sequence acquired after 15 minutes as recommended by guidelines 18 and followed by 0.0011 mmol/kg/min for a 20-minute infusion for equilibrium contrast imaging, with a cumulative contrast dose of 0.122 mmol/kg. The T1-mapping sequence (Modified Look-Locker Inversion recovery [MOLLI]) was acquired just before contrast administration and after equilibrium in a short-axis view at the level of the papillary muscles, as previously described. 19 All MOLLI sequences were based on a 3 to 5 scheme using a singleshot steady-state free precession readout sequence (TR/TE/α=2.7 ms/1.36 ms/50°) with an in-plane acquisition resolution of 1.2×1.5 mm, 2 inversion interval of 185 ms, half scan of 0.6, shot duration of 174 ms, and slice thickness of 8 mm. T1 maps were generated by nonlinear fitting of different inversion time points.
Analysis of CMR acquisitions was performed using specialized software (Extended MR Workspace; Philips, The Netherlands) by 2 observers blinded to hemodynamic measurements and histology results. On cine images, biventricular endocardial contours were manually traced in end diastole and end systole, and Simpson's method was used to calculate volumes and ejection fraction. For phase-contrast analysis, the inner contour of the main PA and ascending aorta were outlined in each cardiac phase to quantify the minimum and maximum areas, average velocities, and stroke volumes. Similarly, the inner contours of the shunt were outlined in each cardiac phase to quantify the stroke volume through the shunt. Ventricular volumes and masses and PA areas were adjusted to body surface area. RV-arterial coupling (E a /E max ) was estimated as ([mean PAP− LVEDP]/RV stroke volume index/[mean PAP/ RV end-systolic volume index]) 20 using the hemodynamic data registered immediately before the CMR. Regions of interest were drawn on T1 maps in the myocardial RV insertion points, septum, LV lateral wall, and LV cavity blood pool before contrast administration and after equilibrium, as previously shown. 19 T1 mapping images were acquired with high in-plane resolution to facilitate drawing the regions of interest inside the myocardium, and heart rate was updated before every MOLLI acquisition to define the right trigger delay to minimize spatial misregistration. Native T1 values were obtained from precontrast T1 map, and ECV values were calculated as previously described. 21 
CT Studies
CT studies were performed on a monthly basis in shunted animals to confirm permeability of the shunt using a 64-slice scanner (Brilliance Philips) with retrospective electrocardiographic gating. Nonionic iodinated contrast agent (30-40 mL; Isovue 300) was injected through a peripheral vein at a rate of 4 mL/s with a power injector followed by a 30 mL saline flush. A bolus tracking technique was used to appropriately trigger image acquisition once attenuation in the RV reached a preset threshold of 100 HU.
Postprocessing of CT images was performed using dedicated software (Extended Brilliance Workspace 3.5; Philips) and included multiplanar, volume-rendered, and shaded-surface display reconstructions. Shunt maximal orthogonal diameters and cross-sectional area were measured at end-diastole.
Histopathology
Masson's trichrome and picrosirius red stainings were used to evaluate microscopic changes and the presence of collagen using a stereomicroscope provided with digital camera (Nikon SM 1500; Nikon). Quantification of the intimal and medial layer thickness in intraparenchymatous arteries was performed on 20 lung samples (right lower pulmonary lobe) from shunted pigs and compared with 20 samples from sham controls.
Morphometric analysis of the collagen network in the RV insertion points and LV lateral wall was performed in 6 shunted animals and 6 sham-operated controls (15 randomly chosen fields [10× magnification] from each specimen) using picrosirius red staining and dedicated software (SigmaScan Pro 5.0; Jandel Scientific). In each field, a grid of vertical and horizontal lines was used, providing 121 intersection points. The proportion of connective tissue in each specimen, expressed as connective tissue density, was defined as the percentage of intersection points occupied by collagen.
Quantification of cellular and extracellular fractions was performed in the same 12 animals (3 randomly chosen fields from each specimen at 40× magnification) using Masson's trichrome staining and ImageJ (National Institutes of Health; MD) to delineate the corresponding areas.
Statistical Analysis
Continuous variables are expressed as median (interquartile range). Comparisons of continuous variables between groups were performed using Mann-Whitney U test. Concordance among CO measured by CMR and thermodilution was assessed with the intraclass correlation coefficient for absolute agreement. Correlations between hemodynamic and CRM parameters were assessed using Pearson or Spearman correlation depending on the association type (linear or curvilinear) evaluated with scatter plots. A P value <0.05 was considered statistically significant. Adjustment for multiple comparisons was not performed. Analyses were performed using SPSS 20 (IBM Corp).
Results
Characterization of the Aorto-Pulmonary Shunt Model
Hemodynamic Data
Hemodynamic data are displayed in Table 1 . All animals with aorto-pulmonary shunt developed PH. As compared with controls, animals with shunts showed significantly higher mean and diastolic PAP already at 1 month after surgery (Figure 2A ). LVEDP and PA wedge pressure were also significantly higher at the first month. Differences in PVR index reached statistical significance at the fourth follow-up visit ( Figure 2B ). No differences were observed in systemic pressures or cardiac index. Oxygen saturation was significantly lower in shunted animals after the third month, and heart rate was significantly higher in shunted animals only at the last visit.
CMR Data
CMR data are displayed in Table 2 . Compared with controls, animals with aorto-pulmonary shunt developed significant RV hypertrophy and dysfunction (increased RV mass from the third month onwards and reduced RV ejection fraction from the second month; Figure 2C ). Significant RV-arterial uncoupling was observed in shunted animals from the second month. On the LV, shunted animals showed progressive remodeling with significant dilatation already from the first month ( Figure 2D ). The main PA was significantly dilated, and PA average flow velocity was reduced from the first month in shunted animals.
The correlation between CO assessed by thermodilution and CMR using different methods in shunted animals was excellent: (1) phase contrast in the PA (intra-class correlation [ICC]=0.895, 95% confidence interval [CI] 0.734-0.957), (2) RV volumetry (ICC=0.961, 95% CI 0.910-0.983), (3) the difference between CO by phase contrast in the aorta and flow through the shunt (ICC=0.813, 95% CI 0.402-0.934), and (4) the difference between CO by LV volumetry and flow through the shunt (ICC=0.948, 95% CI 0.866-0.980). Flow through the shunt showed an excellent concordance with the difference between systemic-to-pulmonary CO as assessed by phase The increase of the flow through the shunt (through-plane phase-contrast acquisition) as the animals grew correlated with the severity of pulmonary hemodynamics and cardiac remodeling ( Figure 3 ). PA average velocity and CMR-estimated PVR using a previously published model 7 correlated with invasive PVR (r=−0.55, P<0.001; and r=0.62, P<0.001).
Cardiac Computed Tomography Data
CT demonstrated patency of the shunt in all cases. Both shunt diameter and cross-sectional area increased during follow-up ( Table 2 ). Shunt area significantly correlated with its flow, as assessed by CMR (r=0.842; P<0.001).
Histopathology Data Right Ventricle
Animals with aorto-pulmonary shunts showed significant RV hypertrophy macroscopically (Figure 4 ). Microscopic analysis evidenced significant cardiomyocyte hypertrophy, interstitial fibrosis, marked muscular fiber disarray, and lymphocytic infiltration with collagen deposition around myocardial vessels.
Morphometric quantitative analysis revealed significantly higher connective tissue density in samples from the RV insertion points in shunted animals as compared with controls (38% [38%-42%] versus 22% [19%-25%]; P=0.002). There was a good correlation between collagen content evaluated by histopathology and CMR-estimated ECV (R=0.79; P=0.004). The extracellular fraction was also significantly higher in shunted animals as compared with controls (median values of 36% versus 24%).
Left Ventricle
Macroscopically, LV hypertrophy was observed. Microscopic analysis showed muscular fiber disarray and interstitial fibrosis, although in a lesser degree than that seen on the RV (Figure 4 ). Quantitative analysis confirmed significantly higher connective tissue density in the LV lateral wall of shunted animals compared with controls (32.5% [31%-33%] versus 26% [25.5%-27.5%]; P=0.024). Similarly, the extracellular fraction in the LV was also significantly higher in shunted animals as compared with controls (median values of 32% versus 29%).
Lung Parenchyma
Arteries inside the lung parenchyma showed increased medial thickening with fiber disarray and increased connective tissue within the media secondary to degeneration and apoptosis of muscular fibers. Endothelial intimal proliferation and fibrosis was evidenced. Significant periadventitial fibrosis and plexiform-like lesions (complex, glomeruloid-like vascular structures originating from the pulmonary arteries) were also observed ( Figure 5 ). Quantitative analysis from lung samples revealed marked increase in medial thickness (0.14±0.08 mm [range 0.06-0.41 mm] versus controls 0.03±0.01 mm [range 0.01-0.06 mm]) and intimal thickness (0.08±0.02 mm [range 0.02-0.12 mm] versus controls 0.01±0.002 mm [range 0.008-0.02 mm]).
Myocardial ECV Quantified by CMR
For this aim, 20 animals were evaluated 3 months after intervention. One shunted animal was excluded because the shunt was occluded on the CT study. Therefore, 19 animals (9 with aorto-pulmonary shunts and 10 sham controls) were included in this analysis. LGE was not observed in any animal. Intraand interobserver concordance for T1 and ECV measurements of our laboratory have been described previously. 19 Compared with sham controls, equilibrium-contrast ECV was significantly higher in shunted animals at the anterior RV Figure 6 shows individual and summarized ECV data at 4 different locations in shunted and control-sham cases.
ECV at the anterior and inferior RV insertion points showed a strong positive correlation with pulmonary hemodynamics and a negative correlation with RV ejection fraction ( Figure 7 ). ECV at both locations correlated also with LV end-diastolic and end-systolic volumes (r=0.68, P=0.001 and r=0.60, P=0.006 for the anterior and r=0.72, P=0.001 and r=0.61, P=0.008 for the inferior RV insertion point). ECV at the anterior RV insertion point significantly correlated with indexed RV mass (r=0.54, P=0.016), whereas the correlation did not reach statistical significance for the inferior RV insertion point (r=0.45, P=0.063). Likewise, ECV at the septum correlated with pulmonary hemodynamics (r=0.54, P=0.018 for indexed PVR and r=0.53, P=0.018 for mean PAP). Finally, 18) , and there was no correlation between heart rate and T1 and ECV measurements (P value >0.5 in all cases).
Discussion
The present study shows that prolonged systemic-to-pulmonary shunting in growing piglets induces biventricular remodeling and myocardial fibrosis that can be detected and monitored using CMR. The main results of the study are the following: (1) T1-mapping sequences on CMR demonstrate increased ECV at the RV insertion points, the interventricular septum, and the LV lateral wall, reproducing the pattern of fibrosis found on pathology in a noninvasive manner; (2) ECV at the RV insertion points strongly correlates with pulmonary hemodynamics and RV systolic function; (3) CMR imaging evidences progressive RV hypertrophy and dysfunction and LV severe dilatation; (4) CO quantified by CMR shows an excellent correlation with CO measured by RHC; (5) flow through the shunt quantified by CMR strongly correlates with the severity of PH, LVEDP, and LV dilatation.
The original model of left-to-right shunt-induced PH in piglets, proposed by Rendas et al 22 in 1979, used a prosthetic graft between the PA and the descending aorta, but achieved only a modest increase in PAP. Rondelet et al 13 and Wauthy et al 15 introduced a modification by anastomosing the left innominate artery to the PA, thus, allowing for progressive increase in shunt size. Both authors reported a moderate increase in systolic PAP after 10 to 12 weeks with arterial medial hypertrophy but not other characteristics of PH. Rondelet et al 16 recently reported the hemodynamic and pathobiological data at 6 months after shunt closure. Prolonged shunting resulted in a modest increase in mean PAP and PVR with a significant decrease in E es /E a ratio evaluated by RV pressure-volume loops and cardiac index. Increased medial thickness in the lung parenchyma and biventricular cardiomyocyte hypertrophy with interstitial fibrosis was found in pathology. They did not perform serial evaluations and, other than data from RV pressure-volume loops, did not describe cardiac remodeling and performance. Also importantly, they did not report the significant changes occurring in the LV we have seen in our study (eg, LV dilatation, interstitial fibrosis, fiber disarray, and increased filling pressures) that are also typically found in patients with CHD similar to our model, like a patent ductus arteriosus.
In the present study, besides serial hemodynamic evaluation and pathology description, we performed a comprehensive characterization of structural cardiac changes that occurred because of pulmonary overcirculation using CMR. We have been able to demonstrate that this model reproduces biventricular remodeling as that observed in patients with left-to-right shunts and proves as an excellent tool to evaluate diagnostic or therapeutic strategies. Significant differences were observed in RV ejection fraction and LV dimensions between shunt cases and sham controls from the second month. In controls, a progressive increase in RV ejection fraction during the study was observed. This may be related with the physiological change in cardiac chamber dimensions and contractility with growth, and it has also been observed in other studies with the same pig breed 23 ; however, this increase in RV ejection fraction was not observed in shunted animals. Hemodynamic findings resembled those previously described, but considerably higher differences between controls and shunted animals were observed. PVR in both shunted and control cases was higher at the first month than later on. The early fall in PVR correlates with the RV ejection fraction finding and might be because of different factors. First, animal growth in the third and four month after birth is fast, and consequently, the increase in lung size and lung vasculature is important and partially compensates the increase in CO. When PVR is indexed by body surface area, this fall is no longer observed. Second, in the adaptation of the RV to PH, it is known that there is an initial increase in RV contractility, which explains why ventriculoarterial coupling is relatively maintained in earlier stages. 24 Indeed, in our study, estimated E a /E max in shunt cases remained relatively stable during follow-up. Both LVEDP and transpulmonary gradient increased during follow-up. The increase in the transpulmonary gradient may be related with the fact that both shunt diameter and flow increased greatly during the study, as opposed to what is seen in patients with prosthetic shunts for palliation of cyanotic heart disease.
As a reflection of more severe PH generated in our model, we observed not only medial hypertrophy but also significant intimal hypertrophy and fibrosis and plexiform-like lesions in the lung parenchyma, typical features of advanced PH. The development of a more severe disease, including histological changes, as compared with previous studies by Wauthy et al and Rondelet et al might partially have been the consequence of using a different pig breed, with greater increase in body weight and shunt growth. Another possible explanation is that, unlike in previous studies, we confirmed by cardiac CT that the shunt was patent in all animals before all follow-up studies. Closure of the shunt before hemodynamic assessment might have partially reduced the severity of PH; we decided to maintain the shunt patent to allow us to make serial evaluations and to reproduce the uncorrected CHD with pulmonary overcirculation scenario as reliably as possible.
We demonstrate that CMR is able to quantify not only macroscopic cardiac changes but also microstructural involvement in a noninvasive way. CMR allowed detection of myocardial ECV expansion that affected the RV insertion points, the interventricular septum, and the LV lateral wall 3 months after intervention. We decided to use this time point to allow comparisons with previous studies using this model because, according to these previous studies, this time was compatible with early PH. Indeed, LGE was not observed in any animal, and RV ejection fraction could be considered as preserved at this time point (median of 57%), although it was reduced as compared with controls. In an experimental model of postcapillary PH induced by pulmonary vein banding, CMRmeasured ECV at the RV insertion points was significantly higher in banded animals than in controls and showed significant correlation with pulmonary hemodynamics and RV performance. 19 In this previous study, only a nonsignificant trend toward higher ECV at the septum and LV lateral wall was observed. 25 In the current model, ECV was again significantly higher at the RV insertion points, showing a good correlation with the severity of PH, but differences in ECV at the septum and LV lateral wall were also significant, reflecting an inherent damage at the LV. Pressure overload and, remarkably, significant lung parenchymal damage 26 seem to induce greater myocardial fibrosis than volume overload. At the time LVEDP reached a clinically significant increase in shunted cases, a significant ECV expansion was already present. Native precontrast T1 values were higher in all territories in shunted animals, although differences did not reach statistical significance, confirming previous data regarding the superiority of ECV over native T1 value for early detection of myocardial damage. Unlike native T1, ECV requires gadolinium administration. Nevertheless, gadolinium is commonly administered in CHD patients, and the incidence of adverse effects related to its use is low. 27, 28 In addition, gadolinium administration allows detection of macroscopic myocardial fibrosis or scarring (LGE), which is considered irreversible and associated with advanced stages of the disease.
The present study may have the following clinical implications: myocardial fibrosis seems to appear very early after aorto-pulmonary shunting, becoming a potential early marker of biventricular remodeling and RV dysfunction; evaluation of diffuse fibrosis by CMR in the setting of pulmonary overcirculation may become a useful tool in the management of patients with CHD; finally, this translational experimental model has the potential to allow the evaluation of new diagnostic tools and therapeutic strategies in this scenario.
Some study limitations should be acknowledged. T1-mapping sequences were only performed in a single time point for all cases, precluding the evaluation of temporal relationships between hemodynamics and the onset of myocardial fibrosis on CMR. Because of the number of comparisons performed and limited sample sizes, a risk for type I error should be acknowledged. Longer follow-up would be necessary to confirm that ECV expansion identifies patients at risk of developing RV failure and its reversibility after surgery. Also, longer follow-up might allow us to see relevant changes in transpulmonary gradient, ventriculo-arterial coupling, and RV dysfunction. In this sense, we are planning to characterize the same model in minipigs whose longer follow-up is not restricted by the accelerated animal growth. Clinical validation in patients with PH because of overcirculation should be performed in the future.
In conclusion, this is the first study that focuses specifically on characterizing biventricular performance and the noninvasive detection of early myocardial fibrosis in a model of aorto-pulmonary shunt. These results may prove useful in the future for monitoring patients with CHD and left-to-right shunting.
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